HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00003002
Recruitment Status : Completed
First Posted : July 30, 2004
Last Update Posted : December 13, 2012
Information provided by (Responsible Party):
University of Washington

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2004
  Actual Study Completion Date : January 2004